Rucha Patil on Hemophilia in the Era of Non-Factor Therapies
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”Hemophilia and Thalassemia Summit 2025 | Mohali–Chandigarh
A brilliant way to wrap up the year — the Hemophilia and Thalassemia Summit 2025, organized by Hemophilia Advocacy Society, Punjab and Dr. Varun Kaul and team, Guru Gobind Singh Medical College and Hospital, Faridkot.
Honoured to contribute as a speaker on “Hemophilia in the Era of Non-Factor Therapies”, and to be a part of an engaging panel discussion on “Emicizumab – Journey Till Now Including Real-World Evidence”, moderated by the phenomenal Dr. Naresh Gupta, alongside co-panelists: Dr. Sheikh Bilal, Dr. S. K. Digra, Dr. Rajeev Sandal, Dr. Parul Bhat and Dr. Varun Kaul.
Congratulations to the entire organizing team for curating such a meaningful and impactful summit — discussions like these pave the way for better care, access and outcomes for the hemophilia and thalassemia community.
A special added bonus during this trip — a visit to PGI Chandigarh to meet and discuss with Dr. Jasmina Ma’am and Dr. Arihant.
Always energising to exchange ideas and align on ways forward for patient care and research.”

Stay updated with Hemostasis Today.
-
Feb 24, 2026, 15:13Tagreed Alkaltham: Equity in Emergency Care Through a Blood Bank Lens
-
Feb 24, 2026, 14:57Joseph Raffaele: Can Improving Mitochondrial Quality in Immune Cells Alter Immune Aging Markers?
-
Feb 24, 2026, 14:56Jan Sloves: Turning Routine Duplex into a Multiparametric Evaluation of Limb Edema
-
Feb 24, 2026, 14:31Augustina Isioma Ikusemoro: What Happens After You Donate Blood?
-
Feb 24, 2026, 14:27Eloïse Laouenan: Rising Risk of Pregnancy Related Venous Thromboembolism
-
Feb 24, 2026, 14:01A European Action Plan on Rare Diseases Is a Necessity, Not an Option – EPODIN
-
Feb 24, 2026, 13:59Riitta Lassila: How APAC Impacts the Interplay Between Complement and Coagulation
-
Feb 24, 2026, 13:29Win Ratio Analysis of Edoxaban vs Dalteparin in Cancer-Associated VTE – JTH
-
Feb 24, 2026, 13:28EAHAD Welcomes New Members to the Nurses Committee